Convertible Completed

Apimeds Pharmaceuticals US equity raising

US$10.9m raised

Announced 1 Dec 2025 · NYSE AMERICAN: APUS

Advisers

Apimeds Pharmaceuticals US

Issuer

Lead managers

Placement agent
EF Hutton (as E.F. Hutton & Co.)
Issuer
Apimeds Pharmaceuticals US
Issuer based in
United States
Completed
27 Feb 2026
Sector
Pharma
Tags
Pharma, Biotech

Similar deals

All pharma deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.